Related Experiment Video
Updated: Jul 6, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.0K
Genetic Testing in Hypertrophic Cardiomyopathy
Catherine G Ireland1, Carolyn Y Ho1
1Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
The American Journal of Cardiology
|February 17, 2024
Summary
Genetic testing aids hypertrophic cardiomyopathy (HCM) diagnosis and management by identifying causative variants. This genetic information is crucial for accurate diagnosis, family screening, and personalized patient care.
Area of Science:
- Cardiovascular Genetics
- Molecular Diagnostics
Background:
- Hypertrophic cardiomyopathy (HCM) diagnosis and management benefit significantly from genetic testing.
- Identifying causative genetic variants is key to understanding disease mechanisms and inheritance patterns.
Purpose of the Study:
- To outline the role and utility of genetic testing in hypertrophic cardiomyopathy (HCM).
- To discuss the implications of genetic testing for patient diagnosis, family screening, and clinical management.
Main Methods:
- Review of current genetic testing methodologies for HCM.
- Analysis of variant identification rates and their clinical significance.
- Discussion of genetic counseling and interpretation of results.
Main Results:
- Modern genetic testing identifies causative variants in 30% to over 60% of HCM patients.
- Test positivity is influenced by patient characteristics, such as family history.
- Positive results clarify diagnosis and facilitate targeted family screening.
Conclusions:
- Genetic testing is an essential tool for diagnosing and managing HCM patients and their families.
- Interpreting genetic test results requires expertise and multidisciplinary collaboration.
- Predictive testing in at-risk family members aids in risk stratification and screening decisions.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...